U.S. stocks have minted a fortune for investors, with the benchmark S&P 500 returning nearly 70% over the past five years.

Healthcare giant Johnson & Johnson (NYSE:JNJ) is one of Jim Cramer’s top healthcare stocks even though the shares have been lackluster. They are up by a modest 27% year-to-date, with most of the gains ...

International Business Machines Corporation (NYSE:IBM) is another stock that Jim Cramer has continued to stick by, even though the shares have struggled. For more than a year, the CNBC TV host has ...

Bill McDermott, ServiceNow chairman and CEO, joins 'Mad Money' host Jim Cramer to recap the company's quarterly results, ...

Jim Cramer’s most durable investing rule is a short one: some stocks you own, and some stocks you trade. For years he has ...

Netflix stock is down 40% over the past year and fell again after earnings. Jim Cramer says the selloff went too far and lays ...

CNBC's Jim Cramer urged investors not to overreact to earnings season volatility, saying short-term market moves often defy ...

'Mad Money' host Jim Cramer weighs in on stocks including: Figma, Solaredge, IONQ, Independent Bank Corp, and Constellation ...

Jim Cramer believes forced selling is creating opportunities, but investors should resist buying too early. During his July ...

In his appearance on CNBC’s Squawk on the Street on Tuesday, Jim Cramer briefly discussed industrial conglomerate 3M Company ...

How dangerous is it when homegrown companies integrate technology from China in the battle for AI dominance?

Even though the shares have been among the top performers in the market, CNBC’s Jim Cramer still believes that Western ...